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Abstract
OBJECTIVE: To evaluate the effects of Jidesheng
anti-venom used externally for skin and soft-tissue
necrosis from Chinese cobra bite.
METHODS: A retrospective review was performed
according to the clinical data recorded from Janu-
ary 2002 to December 2012. A total of 126 patients
(116 females and 10 males) with skin and soft-tis-
sue necrosis due to Chinese cobra bite were divid-
ed into two groups. The control group was treated
externally with 40% glyceride magnesium sulfate
(n=52), and the treatment group was given Jidesh-
eng anti-venom externally (n=74). The data collect-
ed included maximum local necrotic area of skin
and soft tissues, de-tumescence time, healing time,
and skin-grafting rate.
RESULTS: There were no significant differences in
gender, age, and disease condition between the
control and treatment groups (P>0.05). No statisti-
cally significant difference was found in de-tumes-
cence time between the two groups (P>0.05). The
maximum local necrotic area of skin and soft tis-
sues was (19.9 ± 7.3) cm2 in the treatment group,
while it was (23.3 ± 6.4) cm2 in the control group.
The healing time of the treatment group was short-
er than that of the control group [(32.1 ± 3.7) vs
(34.4±4.5) days)] The skin-grafting rate in the treat-
ment group was lower than that of the control
group (10.81% vs 25.00% ). There were statistically
significant differences in maximum local necrotic
area of skin and soft tissues, healing time, and
skin-grafting rate between the control and treat-
ment groups (all P<0.05).
CONCLUSION: External application of Jidesheng
anti-venom may help to promote wound healing
and reduce the skin-grafting rate in cases of skin
and soft-tissue necrosis due to Chinese cobra bite.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
The Chinese cobra (Naja atra) is part of the Elapidae
family. It is one of the ten most venomous snakes in
China, and is mainly distributed in the area to the
south of the Yangtze River.1 The illness caused by Chi-
nese cobra bite is acute and critical, and is commonly
seen in emergency departments. The cobra's venom is
a mixed poison that induces cytotoxicity, which can
quickly necrotize skin and soft tissues. Necrosis is the
most common complication following Chinese cobra
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bite.2 Since anti-cobra venom serum has been used in
clinic, the mortality rate of cobra bites has greatly re-
duced. At present, however, few methods can effective-
ly treat the skin and soft-tissue necrosis due to Chinese
cobra bite. Therefore, we carried out a retrospective
study to evaluate the effects of external Jidesheng an-
ti-venom on skin and soft-tissue necrosis caused by
Chinese cobra bite.
MATERIALS ANDMETHODS
This retrospective study was approved by the Ethics
Committee of Guangxi Medical University, and was
performed according to the clinical data recorded from
January 2002 to December 2012. The criteria for inclu-
sion in the treatment group were: (a) The patient was
diagnosed as having a Chinese cobra bite, with the
snake caught and/or a picture taken as evidence; (b)
the patient had necrotic skin and soft tissues; and (c)
the patient received routine treatment. Patients who
had other kinds of snakebites, had necrosis caused by
other factors, failed to complete the routine treatment,
or were allergic to Jidesheng anti-venom were excluded.
All 126 patients received routine treatment, which in-
cluded: (a) anti-cobra venom injection 50 IU/kg
(Shanghai Serum Biological Technology Co., Ltd.,
Shanghai, China); (b) local block therapy with 5% li-
docaine hydrochloride injection 5 mL (Shanghai Chao-
hui Pharmaceutical Industry Co., Ltd., Shanghai, Chi-
na) and chymotrypsin injection 4000 IU (The first
Chemical Industry Co., Ltd., Shanghai, China); (c)
oral administration of Jidesheng anti-venom tablets, 10
tablets each time, three times a day, for 3 days (Essence
Pharmaceutical Group Co., Ltd., Nantong, China);
and (d) anti-infection management. In addition, exter-
nal medicine application was essential to the local ne-
crotic area, with the dressing changed daily. In total, 52
patients in the control group were treated with an ex-
ternal application of 40% glyceride magnesium sulfate
(Beijing Yanjing Pharmaceutical Co., Ltd., Beijing,
China) and 100 mL glyceride (Hunan Erkang Pharma-
ceutical Co., Ltd., Liuyang, China); the other 74 pa-
tients in the treatment group received an external appli-
cation of Jidesheng anti-venom.
Data collection
(a) disease condition3: Grade Ⅰ: local swelling con-
fined to 1 segments of the bitten limb; minor pain and
general signs (vomiting, headache, abdominal or chest
pain). Grade Ⅱ: local swelling meted 2 segments of
the bitten limb; moderate pain and general signs.
Grade Ⅲ: extension of swelling beyond 2 segments;
persistent and resistant pain to analgesics; severe gener-
al signs. GradeⅣ: swelling spreading to the trunk; dis-
seminated intravascular coagulation; hypotension or co-
ma. (b) the maximum local necrotic area of skin and
soft tissues: we directly calculated the necrotic area by
the measurement of circular and rectangular area, de-
pending on the area looks like circular or rectangular.
Finally, the maximum value was selected for assess-
ment. (c) de-tumescence time, healing time and
skin-grafting rate.
Statistical analysis
The software package SPSS 16.0 (SPSS Inc., Chicago,
IL, USA) was used for all statistical analyses. The data
for the maximum local necrotic area, de-tumescence
time, and healing time are expressed as mean ± SD.
Rank sum test was used to assess disease condition. A
Chi-squared analysis was used to evaluate the differenc-
es in gender and skin-grafting rate between the two
groups. Differences in age, maximum local necrotic ar-
ea, de-tumescence time, and healing time were com-
pared by using the Student's unpaired t-test. A
two-tailed P value less than 0.05 was considered statisti-
cally significant.
RESULTS
Comparison of general data
There were no significant differences in gender, age,
and disease condition between the control and treat-
ment groups (P>0.05) (Table 1, 2).
Comparison of maximum local necrotic area,
de-tumescence time, and healing time between the
control and treatment groups
No statistically significant difference was found in
de-tumescence time between the control and treatment
groups (P>0.05). The maximum local necrotic area of
skin and soft tissues was (19.9±7.3) cm2 in the treat-
ment group, while it was (23.3±6.4) cm2 in the control
Table 1 Comparison of gender and age between control and
treatment groups
Parameter
n
Male/female
Age
Control
group
52
49/3
40±11
Treatment
group
74
67/7
40±10
t (χ2)
-
0.143
﹣0.384
P
value
-
0.706
0.702
Notes: patients in control group received routine treatment. Pa-
tients in the treatment group received routine treatment and an
external application of Jidesheng anti-venom.
Necrotic
classification
GradeⅠ
GradeⅡ
GradeⅢ
GradeⅣ
Control group
(n=52)
10
36
5
1
Treatment group
(n=74)
16
48
8
2
Notes: patients in control group received routine treatment. Pa-
tients in the treatment group received routine treatment and an ex-
ternal application of Jidesheng anti-venom.Z=﹣0.054,P=0.957.
Table 2 Comparison of disease condition between control
and treatment groups
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group. The healing time of the treatment group was
shorter than that of the control group [(32.1 ±3.7) vs
(34.4±4.5) days]. There were statistically significant dif-
ferences in maximum local necrotic area of skin and
soft tissues and healing time between the control and
treatment groups (both P<0.05) (Table 3).
Comparison of skin-grafting rate between the control
and treatment groups
The skin-grafting rate was 10.8% in the treatment
group, which was significantly lower than the control
group at 25.0% (P<0.05) (Table 4).
DISCUSSION
The Chinese cobra has a complex venom mainly con-
sisting of neurotoxins, circulatory toxins, and cytotox-
ins.4-7 Neurotoxins can lead to nerve-muscle block, skel-
etal muscle paralysis, and severe respiratory paralysis.8
Circulatory toxins may cause heart damage, giving rise
to a drop in blood pressure, weakened pulse, shock,
and even death.9 The most common clinical cobra bite
symptoms of skin and soft-tissue swelling and necrosis
are attributed to the cytotoxins. Many clinical reports
indicate that the cytotoxic reaction induced by the Chi-
nese cobra bite is extreme.10
There are many actions of the toxic proteins of Chi-
nese cobra venom responsible for pain, swelling, and
necrosis. Protein hydrolysis can dissolve vessel walls,
cause local tissue necrosis, hemorrhaging, and even
deep tissue ulceration. Phospholipase A2, mainly as a re-
sult of indirect hemolysis,11,12 can decompose lecithin
into lysolecithin, resulting in hemolysis, increased capil-
lary permeability,13 and release of histamine, 5-hydroxy-
tryptamine, and adrenaline, which indirectly affect the
cardiovascular and nervous systems.14 Hyaluronidase
can undermine the integrity of connective tissues and
speed up the spread of venom. Finally, adenosine tri-
phosphatases can destroy adenosine triphosphate, re-
ducing energy supply, affecting the synthesis of neu-
rotransmitters and proteins, resulting in physiological
dysfunction.
Currently, the mechanisms underlying the circulation
of Chinese cobra venom and its pathogenesis are uncer-
tain. In normal circumstances, substances with a molec-
ular weight less than 5 kDa can pass through blood ves-
sels. However, Chinese cobra venom, with a molecular
weight of 11 kDa, cannot easily enter the blood circula-
tion. Therefore, the local symptoms are more severe
than the systemic symptoms.15 Chinese cobra venom
can cause extensive local skin and soft-tissue destruc-
tion, mainly because of the actions of cytotoxins and
phospholipase A2. In contrast, the local actions of viper
snakebites are mainly due to the hemorrhagic metallo-
proteinases, which are responsible for the hemorrhagic
syndrome commonly seen after such envenomation.16
Histopathological studies of Naja bite wounds in hu-
mans have revealed focal necrosis within the epidermis
with thrombosis and fibrinoid deposits in the superfi-
cial and deep dermal vessels, and with features of leuko-
cytoclastic vasculitis.17,18 The extensive local tissue dam-
age from Chinese cobra venom is believed to be caused
not only by the direct cytotoxic actions, but also by
ischemia secondary to vascular change in the dermal
vessels. Most researchers believe that the pathogenic
mechanism for cytotoxins is that they can compromise
the integrity of cell membranes, affecting the balance
of ions inside and outside the cells, which causes cell
swelling, rupture, and death, depending on the charac-
teristic "three-finger" structure of the cytotoxin.19-23 Cy-
totoxins can lead to cell death by compromising the
cell membrane, or cause apoptosis through activated re-
active oxygen species, cytochrome C, and other apop-
totic signals.24
In the present study, there was no statistically signifi-
cant difference in de-tumescence time between the
control group and treatment group. However, there
was a smaller maximum local necrotic area of skin
and soft tissues, a shorter healing time, and a lower
skin-grafting rate in the treatment group than in the
control group. External application of magnesium sul-
fate is usually adopted to reduce local inflammation
and swelling in clinic. Alireza et al 25 reported that
magnesium sulfate can significantly decrease the gap
between drug administration and the start of lido-
caine block, as well as increase the block length. In
addition, magnesium sulfate may help to combat
ischemia-induced cell damage.26 Once the magnesium
sulfate is mixed into glycerol, the glycerol can effec-
tively prevent its evaporation and extend the dura-
tion of action.
Parameter
n
Maximum
local necrotic
area (cm2)
De-tumescence
time (d)
Healing time
(d)
Control
group
52
23.3±6.4
10.6±1.6
34.4±4.5
Treatment
group
74
19.9±7.3
10.1±1.4
32.1±3.7
t (χ2)
-
2.670
1.894
3.20
P
value
-
0.009
0.061
0.002
Table 3 Comparison of maximum local necrotic area, de-tu-
mescence time, and healing time between control and treat-
ment groups
Notes: patients in control group received routine treatment. Pa-
tients in the treatment group received routine treatment and an
external application of Jidesheng anti-venom.
Skin-grafting rate
Skin grafting
No skin grafting
Control group
(n=52)
13 (25.0)
39 (75.0)
Treatment group
(n=74)
8 (10.8)
66 (89.2)
Table 4 Comparison of skin-grafting rate between control
and treatment groups [n (%)]
Notes: patients in control group received routine treatment. Pa-
tients in the treatment group received routine treatment and an
external application of Jidesheng anti-venom.χ2=4.211,P=0.040.
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The main ingredients of Jidesheng anti-venom are Gan-
chan (Succys Bufo), Dijincao (Herba Euphorbiae Humi-
fusae), Chonglou (Rhizoma Paridis Chonglou) and Wu-
gong (Scolopendra). Ganchan (Succys Bufo), can secrete
a type of bradykinin antagonizing peptide, which may
inhibit the secretion of bradykinin to relieve pain,
acute inflammation, edema, and hypotension.27 The fla-
vone glycosides isolated from Dijincao (Herba Euphor-
biae Humifusae) can regulate cellular immunity and de-
lay apoptosis.28 Chonglou (Rhizoma Paridis Chonglou)
is a folk medicinal plant in Asia traditionally used for
the alleviation of pain and elimination of poisoning. It
has the function of enhancing immunity, and decreas-
ing toxicity and anti-apoptosis.29,30 Research has found
that Wugong (Scolopendra) can promote blood circula-
tion and remove blood stasis. In brief, each ingredient
in Jidesheng anti-venom may exert antipyretic, antidot-
al, antiphlogistic, and analgesic effects.
The results from the present study demonstrate that ex-
ternal application of Jidesheng anti-venom may help to
promote wound healing and reduce skin-grafting rate
for skin and soft-tissue necrosis following the Chinese
cobra bite.
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